SILVERARC CAPITAL MANAGEMENT, LLC

BOSTON, MA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 12, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$820.9M2026 Q3+ $33.5M options (notional, not included)
Positions70
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.52.0%

What Changed This Quarter?

18 new stocks bought: CLDX (1.8%), Celldex Therapeutics (1.4%), Rainier Acquisition (1.0%) +1521 positions fully exited: Ark ETF Tr, VCYT, Syndax Pharmaceuticals +18 Biggest add: CELC +60.3% in shares Biggest trim: SNDX -79.6% in shares

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.